Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial

Andrew H. Wei; Gail J. Roboz; Hervé Dombret; Hartmut Döhner; Andre C. Schuh; Pau Montesinos; Dominik Selleslag; Sergey N. Bondarenko; Thomas Prebet; Yinzhi Lai; Barry Skikne; C. L. Beach; Farhad Ravandi

doi:10.3324/haematol.2022.282296

Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial

Andrew H. Wei, Gail J. Roboz, Hervé Dombret, Hartmut Döhner, Andre C. Schuh, Pau Montesinos, Dominik Selleslag, Sergey N. Bondarenko, Thomas Prebet, Yinzhi Lai, Barry Skikne, C. L. Beach, Farhad Ravandi

Leukemia

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2820-2825
Number of pages	6
Journal	Haematologica
Volume	108
Issue number	10
DOIs	https://doi.org/10.3324/haematol.2022.282296
State	Published - Oct 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2022.282296

Cite this

Wei, A. H., Roboz, G. J., Dombret, H., Döhner, H., Schuh, A. C., Montesinos, P., Selleslag, D., Bondarenko, S. N., Prebet, T., Lai, Y., Skikne, B., Beach, C. L., & Ravandi, F. (2023). Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial. Haematologica, 108(10), 2820-2825. https://doi.org/10.3324/haematol.2022.282296

Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial. / Wei, Andrew H.; Roboz, Gail J.; Dombret, Hervé et al.
In: Haematologica, Vol. 108, No. 10, 10.2023, p. 2820-2825.

Research output: Contribution to journal › Letter › peer-review

Wei, AH, Roboz, GJ, Dombret, H, Döhner, H, Schuh, AC, Montesinos, P, Selleslag, D, Bondarenko, SN, Prebet, T, Lai, Y, Skikne, B, Beach, CL & Ravandi, F 2023, 'Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial', Haematologica, vol. 108, no. 10, pp. 2820-2825. https://doi.org/10.3324/haematol.2022.282296

@article{eac2ee438f934a09b83dca9f2dc354fd,

title = "Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial",

author = "Wei, {Andrew H.} and Roboz, {Gail J.} and Herv{\'e} Dombret and Hartmut D{\"o}hner and Schuh, {Andre C.} and Pau Montesinos and Dominik Selleslag and Bondarenko, {Sergey N.} and Thomas Prebet and Yinzhi Lai and Barry Skikne and Beach, {C. L.} and Farhad Ravandi",

year = "2023",

month = oct,

doi = "10.3324/haematol.2022.282296",

language = "English (US)",

volume = "108",

pages = "2820--2825",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

TY - JOUR

T1 - Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy

T2 - subgroup analyses from the phase III QUAZAR AML-001 trial

AU - Wei, Andrew H.

AU - Roboz, Gail J.

AU - Dombret, Hervé

AU - Döhner, Hartmut

AU - Schuh, Andre C.

AU - Montesinos, Pau

AU - Selleslag, Dominik

AU - Bondarenko, Sergey N.

AU - Prebet, Thomas

AU - Lai, Yinzhi

AU - Skikne, Barry

AU - Beach, C. L.

AU - Ravandi, Farhad

PY - 2023/10

Y1 - 2023/10

UR - http://www.scopus.com/inward/record.url?scp=85174080407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85174080407&partnerID=8YFLogxK

U2 - 10.3324/haematol.2022.282296

DO - 10.3324/haematol.2022.282296

M3 - Letter

C2 - 36951156

AN - SCOPUS:85174080407

SN - 0390-6078

VL - 108

SP - 2820

EP - 2825

JO - Haematologica

JF - Haematologica

IS - 10

ER -

Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this